Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Santel Donald J, Director. Insider active across 3 companies, notably Oyster Point Pharma, Inc.. In total, 4 reports have been recorded. History available since 30 July 2021. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Donald J. Santel is a Board Member at Oyster Point Pharma, Inc. and Surrozen, Inc. He contributes to the governance of these companies, bringing his expertise in strategy and management. His role is essential in guiding their development.